Used in pharmaceutical research as a chiral intermediate for synthesizing bioactive molecules, particularly in the development of kinase inhibitors. Its structural features support high selectivity and binding affinity in targeted therapies, especially in oncology and inflammatory disease research. The compound’s dihydrooxazole core and substituted aryl groups enhance metabolic stability and pharmacokinetic properties in drug candidates.